Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma
Clinical trial NCT06894979 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06894979
- Sponsor
- Children's Oncology Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-18
- Primary completion
- 2028-03-31
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.